OmniAb (OABI) Other Working Capital Changes (2022 - 2026)
OmniAb (OABI) posted quarterly Other Working Capital Changes of -$748000.0 for Q1 2026, down 9.2% year-over-year from -$823762.1 in Q1 2025, and up 58.88% quarter-over-quarter from -$1.8 million in Q4 2025.
OmniAb (OABI) Other Working Capital Changes (2022 - 2026) Analysis & Trends
OmniAb (OABI) has reported Other Working Capital Changes for 5 consecutive years, with -$748000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 9.2% year-over-year to -$748000.0; the TTM figure through Mar 2026 stood at -$2.9 million (up 52.15% YoY), while the FY2025 annual figure was -$2.8 million, up 52.74% from the prior year.
- Other Working Capital Changes grew to -$748000.0 in Q1 2026 per OABI's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.9 million in Q4 2022 and bottomed at -$1.4 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged $138117.6 across 5 years, with a median of -$52000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 211.82% — and 2024, when it plunged 222.87%.
- OmniAb's Other Working Capital Changes stood at -$3.1 million in 2022, then surged by 211.82% to $3.5 million in 2023, then slumped by 222.87% to -$4.3 million in 2024, then surged by 57.36% to -$1.8 million in 2025, then jumped by 58.88% to -$748000.0 in 2026.
- Business Quant data shows OABI's Other Working Capital Changes at -$748000.0 in Q1 2026, -$1.8 million in Q4 2025, and $370000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 276,000.00 |
| Jun 30, 2026 | 276,000.00 |
| Jun 30, 2026 | 276,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Dec 31, 2025 | 787,000.00 |
| Dec 31, 2025 | 787,000.00 |
| Dec 31, 2025 | 787,000.00 |
| Sep 30, 2025 | 457,000.00 |
| Sep 30, 2025 | 457,000.00 |
| Sep 30, 2025 | 457,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -301,000.00 |
| Dec 31, 2024 | -301,000.00 |